establishing a medical psilocybin advisory board to assess the advantages and disadvantages of the use of psilocybin for therapeutic purposes.

Official Bill Page

Loading official bill page…

17 actions

May 5, 2026 upper

Inexpedient to Legislate, MA, VV === BILL KILLED ===; 05/07/2026; SJ 11
Apr 23, 2026 upper

Committee Report: Inexpedient to Legislate, 05/07/2026, Vote 4-0, CC; SC 17
Apr 1, 2026 upper

Hearing: 04/08/2026, Room 100, SH, 09:45 am; SC 13
Mar 30, 2026 upper

Introduced 03/26/2026 and Referred to Health and Human Services; SJ 7
Mar 26, 2026 lower

Ought to Pass with Amendment 2026-1201h: MA VV 03/26/2026 HJ 9 P. 43
Mar 26, 2026 lower

Amendment # 2026-1201h (NT): AA DV 248-101 03/26/2026 HJ 9 P. 42
Mar 26, 2026 lower

Inexpedient to Legislate: MF DV 127-222 03/26/2026 HJ 9 P. 42
Mar 19, 2026 lower

Minority Committee Report: Ought to Pass with Amendment # 2026-1201h (NT)
Mar 19, 2026 lower

Majority Committee Report: Inexpedient to Legislate 03/17/2026 (Vote 13-11; RC)
Mar 13, 2026 lower

Executive Session: 03/17/2026 10:00 am GP 230
Mar 9, 2026 lower

Division III Work Session: 03/13/2026 09:00 am GP 234
Feb 12, 2026 lower

Referred to Finance 02/12/2026 HJ 4 P. 7
Feb 12, 2026 lower

Ought to Pass: MA VV 02/12/2026 HJ 4 P. 7
Feb 3, 2026 lower

Committee Report: Ought to Pass 01/28/2026 (Vote 18-0; CC) HC 6 P. 7
Jan 21, 2026 lower

Executive Session: 01/28/2026 02:30 pm GP 158
Jan 8, 2026 lower

Public Hearing: 01/14/2026 03:00 pm GP 158
Dec 18, 2025 lower

Introduced 01/07/2026 and referred to Health, Human Services and Elderly Affairs HJ 1 P. 37